Medication overuse headache

Minerva Medica

Volumn 98, Issue 3, 2007, Pages 221-231

  Lenaerts, M E ^a   Couch, J R ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Analgesic overuse headache; Headache, diagnosis; Headache, etiology

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTALBITAL; BUTORPHANOL; CODEINE; DIHYDROERGOTAMINE; DOXEPIN; ERGOTAMINE; HYDROCODONE; HYDROXYZINE; MECLOFENAMATE SODIUM; METOCLOPRAMIDE; MORPHINE SULFATE; NALBUPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PETHIDINE; PROPRANOLOL; STEROID; TOPIRAMATE; TRAMADOL; TRIPTAN DERIVATIVE; UNINDEXED DRUG; VALPROIC ACID;

COMORBIDITY; DISEASE PREDISPOSITION; DRUG ABUSE; DRUG DOSE REDUCTION; DRUG POTENTIATION; HEADACHE; HUMAN; INTRACTABLE PAIN; MIGRAINE; PATHOGENESIS; PATIENT EDUCATION; PHONOPHOBIA; PREVALENCE; PROGNOSIS; PROPHYLAXIS; REVIEW; TENSION HEADACHE;

ACETAMINOPHEN; ADULT; ANALGESICS; DRUG COMBINATIONS; FEMALE; HEADACHE; HUMANS; HYDROCODONE; MIGRAINE DISORDERS; SYNDROME;

EID: 35348908537     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Boes CJ, Capobianco DJ. Chronic migraine and medication-overuse headache through the ages. Cephalalgia 2005;24:378-90.
2. Peters GA, Horton BT. Headache with special reference to the excessive use of ergotamine tartrate and dihydroergotamine. J Lab Clin Med 1950;36:972.
3. Horton BT, Peters GA. Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 1963;1:214-27.
4. Friedman AP, Brazil P, von Storch TJ. Ergotamine tolerance in patients with migraine. JAMA 1955;157: 881-4.
5. Andersson PG. Ergotamine headache. Headache 1975;15:118-21.
6. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol 1982;33:335-41.
7. Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982;22:66-8.
8. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet_Neurol 2004;3:475-83.
9. nd Ed. Cephalalgia 2004;24:S1-160.
10. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996;47:871-5.
11. Headache Classification Committee, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006;26:742-6.
12. Bigal M, Rapoport A, Sheftell F, Tepper S, Lipton R. The International Classification of Headache Disorders revised criteria for chronic migraine-field testing in a headache specialty clinic. Cephalalgia. In press 2007.
13. Katsarava Z, Diener HC, Limmroth V. Medication overuse headache. A focus on analgesics, ergot alkaloids, and triptans. Drug Safety 2001;24:921-7.
14. Rapoport A, Weeks R, Sheftell F. Analgesic rebound headache: theoretical and practical implications. In: Olesen J, Tfelt-Hansen P, Jensen K, editors. Headache 1985. Proceedings Second International Headache Congress. Copenhagen; Copenhagen: Stougaard Jensen; 1985. p. 448-9.
15. Couch, JR. Chronic Daily Headache. Curr Treatment Options Neurol 2003;5:467-79.
16. Young WB. Clinical science: treatment of medication overuse headache and long-term outcome. Headache Curr 2004;1:55-9.
17. Couch JR. Can medication overuse headache be treated by abrupt withdrawal of the overused agent? Nat Clin Pract Neurol 2006;2:654-5.
18. Pascual J, Colas R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep 2001;5:529-36.
19. Scher AI, Stewart WF, Lieberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache 1998;38:497-506.
20. Saper JR, Dodick D, Gladstone JP. Management of chronic daily headache: challenges in clinical practice. Headache 2005;45:S74-85.
21. Wiendels NJ, Knuistingh Neven A, Rosendaal FR, Spinhoven P, Zitman FG, Assendelft WJ et al. Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia 2006;26:1434-42.
22. Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headache de novo? Headache 1988;38:61-2.
23. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003;43: 179-90.
24. Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J. Analgesic use: a predictor of chronic pain and medication overuse headache. The Head-HUNT Study. Neurology 2003;61:160-4.
25. Srikiatkhachorn A. Chronic daily headache: a scientist's perspective. Headache 2002;42:532-7.
26. Silberstein SD, Schulman EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache 1990;30:334-9.
27. Rapoport AM. Analgesic rebound headache. Headache 1988;28:662-5.
28. Suhr B, Evers S, Bauer B, Gralow I, Grotemeyer KH, Husstedt IW. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 1999;19:5-49.
29. Trucco M, Meineri P, Ruiz L; "Gruppo Neurologico Ospedaliero Interregionale per lo Studio delle Cefalee" (Neurological Hospital Interregional Group for the Study of Headache). Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache. J Headache Pain 2005;6:334-7.
30. Warner JS. Prolonged recovery from rebound headaches. Headache 2001;41:817-22.
31. Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson B. Management of chronic tension-type headache with tricyclic antidepressant medication, stress-management therapy, and their combination: a randomized controlled trial. JAMA 2001;285: 2208-15.
32. Couch JR. Evaluation of amitriptyline in the prophylaxis of migraine headache. Arch Neurol 1979;36:695-9.
33. Schnider P, Aull S, Baumgartner C, Marterer A, Wöber C, Zeiler K et al. Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year follow-up. Cephalalgia 1996;16:481-5.
34. Mathew NT, Kurman R, Perez F. Drug induced refractory headache - clinical features and management. Headache 1990;30:634-8.
35. Lenaerts M, Bastings E, Sianard J, Schoenen J. Sodium valproate in severe migraine and tension-type headache: an open study of long-term efficacy and correlation with blood levels. Acta Neurol Belg 1996;96:126-9.
36. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N et al.; on behalf of the Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007;47:170-80.
37. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006;26:1192-8.
38. Pascual J, Rivas MT, Leira R. Testing the combination beta-blocker plus topiramate in refractory migraine. Acta Neurol Scand 2007;115: 81-3.
39. Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000;20:107-13.
40. Jauslin P, Goadsby PJ, Lance JW. The hospital management of severe migrainous headache. Headache 1991;31:658-60.
41. Freitag FG. Preventive treatment for migraine and tension-type headaches. Do drugs having effects on muscle spasm and tone have a role? CNS Drugs 2003;17:373-81.
42. Jelinski SE, Magnusson JE, Becker WJ; CHORD Study Group. Factors associated with depression in patients referred to headache specialists. Neurology 2007;68:489-95.
43. Saper JR, Lake AE 3rd. Medication overuse headache: type I and type II. Cephalalgia 2006;26:1262.
44. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression (or for chronic daily headaches)-clinical lessons. Headache 2006;46:S144-6.
45. Lake AE 3rd. Medication overuse headache: biobehavioral issues and solutions. Headache 2006;46:S88-97.
46. Katsarava Z, Limmroth V, Finde M, Diener HC, Fritsche G. Rate and predictors for relapses in medication overuse headache: a one year prospective study. Neurology 2003;60:1682-3.
47. Baumgartner C, Wessely P, Bingöl C, Maly J, Holzner F. Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 1989;29: 510-4.
48. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes. Cephalalgia 2004;24:483-90.
49. Wang SJ, Fuh JL, Lu SR, Juang KD. Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study. Neurology 2007;68:591-6.